• Ginsenoside Rg1: Protocols and Troubleshooting in Neuroprote

  2026-06-12

  Ginsenoside Rg1, a Panax-derived triterpene saponin, is redefining experimental neuroprotection through precise modulation of neuroimmune pathways. This guide delivers protocol-driven insights, troubleshooting strategies, and actionable workflows for apoptosis and inflammation research, all anchored by recent advances in post-anesthesia neuroprotection.

• EDI3 Inhibition Reduces Tumor Growth in HER2+ Breast Cancer

  2026-06-12

  Keller et al. identified glycerophosphodiesterase EDI3 as a metabolic vulnerability in ER-HER2+ breast cancer cells that are resistant to HER2-targeted therapy. Their study demonstrates that targeting EDI3 impairs tumor cell viability and growth, suggesting a novel metabolic intervention point for overcoming therapeutic resistance.

• Glabridin-Gold(I) Complex 6d: A Synergistic Immunomodulator

  2026-06-11

  This study introduces a glabridin-gold(I) complex (6d) that synergistically targets TrxR and MAPK pathways to enhance antitumor immunity in liver cancer. By modulating both tumor immunogenicity and the immunosuppressive microenvironment, 6d offers a promising strategy to boost immunotherapy efficacy.

• Hydroxyl Radical Degradation Mechanisms of Dimetridazole Exp

  2026-06-11

  This study delivers a quantum chemical analysis of how hydroxyl radicals degrade Dimetridazole (1,2-Dimethyl-5-nitroimidazole) in water, with detailed mechanistic and kinetic data. The findings reveal both efficient breakdown and transient toxicity risks, providing a foundation for improved removal strategies and environmental risk assessment.

• Catalpol Inhibits Liver Fibrosis via EphA2/FAK/Src Pathway M

  2026-06-10

  This study reveals catalpol’s ability to attenuate liver fibrosis by targeting metabolic reprogramming in hepatic stellate cells through direct inhibition of the EphA2/FAK/Src signaling axis. The findings underscore the therapeutic potential of modulating Src kinase pathways in fibrotic disease and provide mechanistic clarity for future antifibrotic drug design.

• Tetrazolium (chloride): Redefining Tissue Viability in Ische

  2026-06-10

  This thought-leadership article illuminates the central role of Tetrazolium (chloride) (TTC, Tetrazolium Red) as a mechanistic probe in ischemic injury research. By marrying mitochondrial redox biology with translational assay workflows, it provides strategic guidance for researchers bridging bench to bedside, highlighting recent advances—such as the interplay between TTC-based viability assays and molecular interventions like cardamomin. The discussion goes beyond conventional product pages, positioning APExBIO's Tetrazolium (chloride) as a cornerstone for rigorous, reproducible preclinical and translational studies.

• Microbiota–Tryptophan–AhR Axis Drives Intestinal Repair in U

  2026-06-09

  Li et al. (2026) reveal that Huangqin decoction promotes ulcerative colitis repair by modulating the gut microbiota to enhance tryptophan-derived aryl hydrocarbon receptor (AhR) ligands, thereby activating AhR signaling and stimulating intestinal stem cell differentiation. This study provides mechanistic clarity on the microbiota–tryptophan–AhR–stem cell axis, suggesting new research directions for targeted mucosal regeneration in inflammatory bowel disease.

• Ertugliflozin Prevents Insulin Signaling Disruption in Alzhe

  2026-06-09

  This study demonstrates that the SGLT2 inhibitor ertugliflozin mitigates cognitive impairment and tau hyperphosphorylation in a rat model of Alzheimer’s disease (AD) by restoring brain insulin signaling. The findings highlight ertugliflozin’s potential for counteracting AD-like pathology via modulation of insulin pathways, offering new insight into the neuroprotective capacity of antidiabetic agents.

• S-Adenosylhomocysteine: Advanced Utility in Neural Metabolis

  2026-06-08

  Explore how S-Adenosylhomocysteine (SAH) enables precision control of methylation and neural metabolism in advanced research. This article uniquely bridges metabolic regulation with neuronal differentiation models, highlighting SAH’s pivotal role and practical assay guidance.

• Docosahexaenoic Acid (DHA): Reliable Solutions for Cell Assa

  2026-06-08

  This article delivers evidence-based guidance for biomedical researchers and lab technicians using Docosahexaenoic Acid (DHA), specifically SKU C4188, in cell viability and neuroprotection assays. It addresses real-world challenges such as oxidative stress, apoptosis modulation, and protocol optimization, while highlighting how APExBIO's DHA ensures reproducibility, solubility, and workflow safety.

• Pertussis Toxin: Mechanisms and Innovations in Immune Modula

  2026-06-07

  Explore the advanced mechanisms of Pertussis toxin, a key AB5-type protein exotoxin, and its distinct role in immune response modulation. This article delivers a deeper scientific perspective and practical assay insights not covered elsewhere.

• Sunitinib: Multi-Targeted RTK Inhibitor for Precision Oncolo

  2026-06-06

  Sunitinib empowers researchers to dissect tumor angiogenesis and apoptosis with robust, quantitative control in advanced cancer models. This guide delivers actionable workflows, troubleshooting strategies, and translational insights grounded in the latest evidence, including biomarker-driven innovations for ATRX-deficient glioma.

• EZ Cap™ Human PTEN mRNA (ψUTP): Innovations in mRNA Delivery

  2026-06-05

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP) advances in vitro transcribed mRNA technology for cancer research, with a unique focus on nanoparticle-mediated delivery and translational assay design. Uncover expert insights into mRNA stability, immune evasion, and next-generation pathway inhibition.

• Quercetin Protects Cataract Lenses via Hippo Pathway Modulat

  2026-06-05

  This study elucidates how quercetin mitigates cataract formation by modulating the Hippo signaling pathway, demonstrating both biochemical and histological lens protection in UVB-induced mouse models. The findings highlight Hippo pathway suppression as a key mechanism for enhanced epithelial cell survival and suggest translational potential for non-surgical cataract interventions.

• Ziprasidone Hydrochloride: Mechanistic Insights and Translat

  2026-06-04

  Explore the unique antitumor mechanisms of Ziprasidone Hydrochloride (Ziprasidone HCl), including its dual receptor antagonism and GOT1 inhibition. This article provides a deep scientific analysis and practical guidance for advanced translational and preclinical oncology research.

15296 records 1/1020 page Next 12345 下5页 Last page